Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alkermes, Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Completed the treatment period of Study ALK9072-003EXT
Continues to require chronic treatment with an antipsychotic medication
Continues to reside in a stable living situation
Continues to have an identified reliable informant
You may not be if
Abnormal clinical laboratory value, vital sign, or electrocardiogram (ECG) finding during participation in Study ALK9072-003EXT that was clinically relevant and related to study drug
Missed more than 1 scheduled study visit during participation in the preceding Study ALK9072-003EXT
Has a significant or unstable medical condition that would preclude safe completion of the current study
Subject is pregnant or breastfeeding
Subject expects to be incarcerated, or has pending legal action which may impact compliance with study participation or procedures
Clareo Health | An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
